A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery.
about
Randomized controlled multicenter trial on the effectiveness of the collagen hemostat Sangustop® compared with a carrier-bound fibrin sealant during liver resection (ESSCALIVER study, NCT00918619).Anaesthetic and pharmacological techniques to decrease blood loss in liver surgery: a systematic review.Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives DatabaseA multicentre, prospective, randomized, controlled trial comparing EVARREST™ fibrin sealant patch to standard of care in controlling bleeding following elective hepatectomy: anatomic versus non-anatomic resectionA hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding.Efficacy of Oxidized Regenerated Cellulose, SurgiGuard®, in Porcine Surgery.Minimizing blood loss during hepatectomy: a literature review.Use of local pro-coagulant haemostatic agents for intra-cavity control of haemorrhage after trauma.An update on topical haemostatic agents in liver surgery: systematic review and meta analysis.Methods to decrease blood loss during liver resection: a network meta-analysis.Characterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F.Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial.
P2860
Q33906505-9324094B-5423-47D4-B43D-297FE56280D5Q35663399-13125DE5-1674-4EF2-9A00-CD219921C44DQ35891985-073E61B1-9C43-48AE-BC0D-5254BAD93F90Q36747338-E9736148-669F-4A1A-9D3D-BB822DDC68EBQ37284019-479E7C8B-AE33-4EAD-A6CA-AF8B48F16DACQ37438349-3A872521-0FDB-49C6-9A05-A632D61FC4BBQ38180642-0B5C4341-8D8B-4897-BA56-E3FE4C5D635CQ38513918-4CBA5C54-8FB1-430C-909D-08BCB7F7CE43Q38942569-7FB6907F-6FB6-4C3B-BE3F-7CEE539F69D6Q38994915-541FC174-0E1C-4B57-AE0D-7BE2741E9BC2Q48557536-F7CD25C3-019A-4233-90CB-B7D7C75347E4Q53217382-ECC39729-1C11-4085-B50E-1CB33E0589D6
P2860
A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A phase III, randomized, contr ...... ring elective hepatic surgery.
@ast
A phase III, randomized, contr ...... ring elective hepatic surgery.
@en
type
label
A phase III, randomized, contr ...... ring elective hepatic surgery.
@ast
A phase III, randomized, contr ...... ring elective hepatic surgery.
@en
prefLabel
A phase III, randomized, contr ...... ring elective hepatic surgery.
@ast
A phase III, randomized, contr ...... ring elective hepatic surgery.
@en
P2093
P2860
P1476
A phase III, randomized, contr ...... ring elective hepatic surgery.
@en
P2093
Babahai Patel
Craig Fischer
James Hart
Jeffrey Hammond
Jessica Shen
Jonathan B Koea
Jonathan Batiller
O James Garden
P2860
P356
10.1111/J.1477-2574.2012.00583.X
P577
2012-10-16T00:00:00Z